Listen Now
Why Drug Safety Surveillance Needs Continuous Innovation
Increased awareness of drug safety during the recent COVID-19 pandemic has resulted in a greater number of reported adverse events. However, healthcare’s enhanced focus on patient-centered approach requires an understanding of the multitude of factors that can influence how a drug interacts with a patient’s life. Extensive availability of RWD such as medical claims and EHRs enable a better understanding of a drug safety profile and the generation of RWE to support the safety decisions.
The Saama Safety Signals podcast provides a stage for pharmacovigilance and drug safety leaders and innovators to tell their stories and perspectives on adopting modern technologies for pharmacovigilance, benefit-risk management, and epidemiology.
About Saama Safety Signals
Introducing Safety Signals, the show for pharmacovigilance professionals, benefit risk managers, epidemiologists, and other patient safety stakeholders. From pharma leaders to academics and scientists, we provide expert perspectives on the challenges, opportunities, and technologies that are shaping the future of the safety sciences. Get ready to be inspired and energized as you work to reduce the risk of life-changing–and life SAVING–medical treatments.
